The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global flow cytometry market size reached US$ 4.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.0 Billion by 2027, exhibiting a growth rate (CAGR) of 8.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Flow cytometry refers to a biophysical and laser-based analytical technology that is used in the analysis of the cells or micelles that are usually suspended in a fluid using a laser beam. This technique aids in subclassifying cell types and detecting residual levels of disease through probes to develop the best treatment plan for the patient. Fluorescent probes, such as bisoxonol, can bind to proteins present on the cell membrane to facilitate the identification of various stages of cell injuries or necrosis. This technique also aids in understanding the structure and composition of the cells for chromosome analysis, cancer diagnosis, protein expression and diagnosis of diseases and hematological malignancies.
The increasing prevalence of chronic medical ailments, such as HIV-AIDS and cancer, is one of the key factors driving the growth of the market. The diagnosis of these diseases requires toxicity testing and an accurate, rapid and sensitive prognosis technique, which, in turn, is creating a positive outlook for the market growth. Furthermore, the widespread adoption of stem cell therapy is also enhancing the utilization of flow cytometry. Rising awareness regarding the benefits of this technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is acting as another major growth-inducing factor. Additionally, several technological advancements, such as the integration of flow cytometry devices with artificial intelligence (AI) platforms, along with the advent of advanced methods, are also contributing to the market growth. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global flow cytometry market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and service, technology, application and end-user.
Breakup by Product and Service:
Breakup by Technology:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Apogee Flow Systems Ltd., BD (Becton, Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc., Luminex Corporation, Merck KGaA, Sony Biotechnology Inc., Sysmex Partec GmbH, Thermo Fisher Scientific Inc., etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product and Service, Technology, Application, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Agilent Technologies Inc., Apogee Flow Systems Ltd., BD (Becton, Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc., Luminex Corporation, Merck KGaA, Sony Biotechnology Inc., Sysmex Partec GmbH and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
The global flow cytometry market was valued at US$ 4.9 Billion in 2021.
We expect the global flow cytometry market to exhibit a CAGR of 8.4% during 2022-2027.
The high prevalence of several chronic medical ailments, along with the increasing awareness towards
the benefits of flow cytometry technology in immunophenotyping, cell sorting, cell proliferation assays,
etc., is primarily driving the global flow cytometry market.
The sudden outbreak of the COVID-19 pandemic has led to the rising adoption of flow cytometry
technology for conducting immunophenotyping, that aid in the development of novel drugs for treating
the coronavirus infection.
Based on the product and service, the global flow cytometry market has been segregated into
instruments, reagents and consumables, accessories, software, and services. Among these, instruments
hold the majority of the total market share.
Based on the technology, the global flow cytometry market can be categorized into cell-based flow
cytometry and bead-based flow cytometry. Currently, cell-based flow cytometry exhibits a clear
dominance in the market.
Based on the application, the global flow cytometry market has been divided into oncology, drug
discovery, disease diagnosis, stem cell therapy, organ transplantation, hematology, and others. Among
these, oncology accounts for the majority of the global market share.
Based on the end-user, the global flow cytometry market can be segmented into hospitals and clinics,
academic and research institutes, pharmaceutical and biotechnology companies, and others. Currently,
hospitals and clinics hold the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global flow cytometry market include Agilent Technologies Inc.,
Apogee Flow Systems Ltd., BD (Becton, Dickinson and Company), Beckman Coulter Inc. (Danaher
Corporation), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc., Luminex Corporation, Merck KGaA, Sony
Biotechnology Inc., Sysmex Partec GmbH, Thermo Fisher Scientific Inc., etc.
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at